FDA targets companies selling unapproved products for treating opioid addiction
On Jan. 24, the U.S. Food and Drug Administration (FDA) announced that along with the Federal Trade Commission it posted joint warning letters to…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.